Offer - Urjas Oil for just ₹ 1 X
Gibtulio Met 12.5/500 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes Type 2.
The correct dosage of Gibtulio Met 12.5/500 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Gibtulio Met 12.5/500 Tablet also has some side effects, the most common being Respiratory tract infection, Nausea or vomiting. While these are the most often observed Gibtulio Met 12.5/500 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Gibtulio Met 12.5/500 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Gibtulio Met 12.5/500 Tablet has a Severe effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Gibtulio Met 12.5/500 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Kidney Disease, Diabetes Type 1 must refrain from the use of Gibtulio Met 12.5/500 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Gibtulio Met 12.5/500 Tablet are listed in the contraindications section below.
Additionally, Gibtulio Met 12.5/500 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Gibtulio Met 12.5/500 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Gibtulio Met 12.5/500 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gibtulio Met 12.5/500 Tablet safe for pregnant women?
Gibtulio should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Gibtulio Met 12.5/500 Tablet safe during breastfeeding?
Gibtulio can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Gibtulio Met 12.5/500 Tablet on the Kidneys?
Gibtulio rarely affects the kidneys.
What is the effect of Gibtulio Met 12.5/500 Tablet on the Liver?
Using Gibtulio does not have any harmful effects on the liver.
What is the effect of Gibtulio Met 12.5/500 Tablet on the Heart?
Gibtulio has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Gibtulio Met 12.5/500 Tablet unless your doctor advises you to do so -
Is this Gibtulio Met 12.5/500 Tablet habit forming or addictive?
Gibtulio Met 12.5/500 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Gibtulio Met 12.5/500 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Gibtulio Met 12.5/500 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Gibtulio Met 12.5/500 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Gibtulio Met 12.5/500 Tablet
It is safe to take Gibtulio Met 12.5/500 Tablet with food.
Interaction between Alcohol and Gibtulio Met 12.5/500 Tablet
Taking Gibtulio Met 12.5/500 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jardiance® (empagliflozin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 491-493